Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Thu, Nov 6th, 2025

Biotechnology Stocks

A list of publicly traded biotechnology and biotech-related stocks and ETFs.
Thu, Nov 6th, 2025

Biotechnology (biotech) Stocks are publicly traded companies that develop pharmaceutical drugs used in the treatment of disease. You can use Barchart's Biotech Stocks list to find investment opportunities and compare stocks involved in this hot industry.

View Profiles of these companies.

Biotechnology Stocks News

Federal health officials push effort to spur cheaper biotech drugs

Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend on to treat autoimmune diseases or cancers

1 Growth Stock Under $100 to Buy Before It Soars

This biotech under $100 looks like a growth opportunity worth grabbing before it soars.

INCY : 105.20 (-0.47%)
5 Under-the-Radar Biotech Stocks That Could Soar in 2026

These smaller innovators are quietly advancing promising therapies that could unlock their true potential.

SLN : 6.45 (+3.37%)
CRDL : 1.0200 (-6.42%)
TERN : 18.25 (+0.33%)
INO : 2.25 (-1.75%)
TARA : 4.29 (-3.38%)
ATRA : 11.82 (+9.95%)
Can This Red-Hot Biotech Stock Live Up to Wall Street’s Expectations?

Adaptive Biotechnologies (ADPT) is a commercial-stage biotech with strong technical momentum. Shares are up 250% in the past year and just hit a new three-year high. ADPT maintains a 100% “Buy” opinion...

ADPT : 15.56 (-11.54%)
This ‘Strong Buy’ Stock Has More Than Tripled Today. Should You Buy It Here?

Praxis shares soar as the biotech firm reports promising late-stage results for ulixacaltamide. Here’s why it may not be too late to invest in PRAX shares.

PRAX : 172.35 (+4.68%)
3 Biotech Stocks That Could More Than Triple if Their Trials Succeed

While the risks remain significant with biotech stocks, the potential rewards could be equally compelling.

ATXS : 12.43 (-1.51%)
AVTX : 15.42 (-6.26%)
GOSS : 2.31 (-2.53%)
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar